David J Chung

22PUBLICATIONS
150CO-AUTHORS
Disease surveillanceInfectious diseasesCancer geneticsMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 30, 2026
Administration-related reactions following first-dose subcutaneous daratumumab to inform implementation of a 30-minute observation period.

|Feb 24, 2026
Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma.

William A Wood, Shaji K Kumar, Emily Semmel

|Dec 04, 2025
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Urvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garcés

|Aug 25, 2025
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance.

Ross S Firestone, Anish K Simhal, Devin McAvoy

|Dec 04, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis.

Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari

|Aug 08, 2024
Regulation of the hematopoietic stem cell pool by C-Kit-associated trogocytosis.

Xin Gao, Randall S Carpenter, Philip E Boulais

Pageof 4

Frequent Collaborators

15 joint publications

Sergio Giralt

14 joint publications

Gunjan Shah

13 joint publications

Heather Landau

13 joint publications

Urvi Shah